These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 21109077)

  • 1. Masseteric venous malformations: diagnosis, treatment, and outcomes.
    Rosbe KW; Hess CP; Dowd CF; Frieden IJ
    Otolaryngol Head Neck Surg; 2010 Dec; 143(6):779-83. PubMed ID: 21109077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous treatment of facial venous malformations: a matched comparison of alcohol and bleomycin sclerotherapy.
    Spence J; Krings T; TerBrugge KG; Agid R
    Head Neck; 2011 Jan; 33(1):125-30. PubMed ID: 20848431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sclerotherapy of peripheral venous malformations: a new technique to prevent serious complications.
    Ierardi AM; Mangini M; Vaghi M; Cazzulani A; Carrafiello G; Mattassi R
    Vasc Endovascular Surg; 2010 May; 44(4):282-8. PubMed ID: 20403950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative sclerotherapy of facial venous malformations: impact on surgical parameters and long-term follow-up.
    James CA; Braswell LE; Wright LB; Roberson PK; Moore MB; Waner M; Buckmiller LM
    J Vasc Interv Radiol; 2011 Jul; 22(7):953-60. PubMed ID: 21550819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: analysis of patient self-assessment and imaging.
    Yun WS; Kim YW; Lee KB; Kim DI; Park KB; Kim KH; Do YS; Lee BB
    J Vasc Surg; 2009 Sep; 50(3):581-9, 589.e1. PubMed ID: 19540703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Image Guided Sclerotherapy of Masseteric Venous Malformations.
    Kumar S; Bhavana K; Kumar B; Sinha AK; Kumar P
    Ann Otol Rhinol Laryngol; 2020 Jun; 129(6):548-555. PubMed ID: 31910645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management of pediatric cervicofacial venous malformations: retrospective review from a vascular anomalies center.
    Glade RS; Richter GT; James CA; Suen JY; Buckmiller LM
    Laryngoscope; 2010 Feb; 120(2):229-35. PubMed ID: 20013849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR imaging-guided percutaneous sclerotherapy of peripheral venous malformations with a clinical 1.5-T unit: a pilot study.
    Andreisek G; Nanz D; Weishaupt D; Pfammatter T
    J Vasc Interv Radiol; 2009 Jul; 20(7):879-87. PubMed ID: 19481473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical treatment of masseteric venous malformations and outcomes.
    Kwon JH; Lim SY; Pyon JK; Mun GH; Bang SI; Oh KS
    J Craniofac Surg; 2014 Mar; 25(2):680-4. PubMed ID: 24621722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsurgical management of vascular malformation of masseter.
    Jayaraman V; Austin RD; Kannan S
    Indian J Dent Res; 2015; 26(1):96-100. PubMed ID: 25961625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective analysis of facial paralysis caused by ethanol sclerotherapy for facial venous malformation.
    Hu X; Chen D; Jiang C; Jin Y; Chen H; Ma G; Lin X
    Head Neck; 2011 Nov; 33(11):1616-21. PubMed ID: 21990226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of intramuscular venous malformations of the masseter muscle.
    Yousaf K; Salahudin O; Rashid M
    J Pak Med Assoc; 2014 Mar; 64(3):355-8. PubMed ID: 24864618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gross hemoglobinuria and oliguria are common transient complications of sclerotherapy for venous malformations: review of 475 procedures.
    Barranco-Pons R; Burrows PE; Landrigan-Ossar M; Trenor CC; Alomari AI
    AJR Am J Roentgenol; 2012 Sep; 199(3):691-4. PubMed ID: 22915413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current concepts in diagnosis and treatment of venous malformations.
    Judith N; Ulrike E; Siegmar R; Matthias N; Jürgen H
    J Craniomaxillofac Surg; 2014 Oct; 42(7):1300-4. PubMed ID: 24969765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of intermuscular venous malformations: A retrospective study in one center.
    Xu M; Wang M; Cheng Y; Ni X; Xu Y; Wang Q; Yuan S
    Phlebology; 2020 Jul; 35(6):384-393. PubMed ID: 31663826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vascular anomalies: information documents].
    Philandrianos C; Degardin N; Casanova D; Bardot J; Petit P; Bartoli JM; Magalon G
    Ann Chir Plast Esthet; 2011 Jun; 56(3):254-64. PubMed ID: 20598795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes and complications of sclerotherapy for venous malformations.
    Qiu Y; Chen H; Lin X; Hu X; Jin Y; Ma G
    Vasc Endovascular Surg; 2013 Aug; 47(6):454-61. PubMed ID: 23759722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of venous malformations.
    Greene AK; Alomari AI
    Clin Plast Surg; 2011 Jan; 38(1):83-93. PubMed ID: 21095474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous Malformations of the Head and Neck.
    Seront E; Vikkula M; Boon LM
    Otolaryngol Clin North Am; 2018 Feb; 51(1):173-184. PubMed ID: 29217061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of intralesional sclerotherapy with 3% sodium tetradecyl sulphate in cutaneous vascular malformations.
    Khandpur S; Sharma VK
    Dermatol Surg; 2010 Mar; 36(3):340-6. PubMed ID: 20100267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.